App aims to curb suicide risk in ERs – 28,000 patients enrolled

NCT ID NCT06311591

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a tablet-based app called Jaspr that helps adults with suicidal thoughts while they wait in the emergency department. The app guides users through suicide risk assessment and safety planning based on proven therapies. Researchers will track whether it reduces suicide attempts and repeat ER visits over 12 months. Over 27,900 participants are being enrolled across multiple sites.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Jaspr App (digital platform on a tablet)
What this could lead to
If effective, this could provide a scalable, evidence-based tool to reduce suicide risk and emergency visits for people in crisis.
What could go wrong
This is a real-world study, not a controlled trial, so results may be influenced by many factors. The app requires English literacy or a proxy, limiting who can use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SELF HARM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies Psychological Well-Being Self-Injurious Behavior Suicidal Ideation Suicide Suicide Prevention Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ohio State East Hospital

    Columbus, Ohio, 43210, United States

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio, 43210, United States

  • UCHealth Memorial Hospital Central

    Colorado Springs, Colorado, 80909, United States

  • UCHealth University of Colorado Hospital

    Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.